Zhao-shi X. Bao

Beijing, 100070, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.

Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.

Journal: Cancer immunology, immunotherapy : CII
Published: April 28, 2021

Mutation and Copy Number Alterations Analysis of KIF23 in Glioma.

Mutation and Copy Number Alterations Analysis of KIF23 in Glioma.

Journal: Frontiers in genetics
Published: January 06, 2021

Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.

Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.

Journal: American journal of cancer research
Published: November 30, 2020

Clinical and Molecular Characterization of Incidentally Discovered Lower-Grade Gliomas with Enrichment of Aerobic Respiration.

Clinical and Molecular Characterization of Incidentally Discovered Lower-Grade Gliomas with Enrichment of Aerobic Respiration.

Journal: OncoTargets and therapy
Published: February 06, 2020

Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.

Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.

Journal: OncoTargets and therapy
Published: November 12, 2019

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.

Journal: Oncology letters
Published: June 03, 2019

Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.

Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.

Journal: Frontiers in immunology
Published: August 16, 2018

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.

Journal: Oncoimmunology
Published: May 07, 2018

Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.

Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.

Journal: Future oncology (London, England)
Published: December 06, 2017

Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.

Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.

Journal: Asian journal of andrology
Published: August 18, 2017

Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.

Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.

Journal: CNS neuroscience & therapeutics
Published: June 19, 2016

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.

Journal: Oncotarget
Published: August 23, 2015
Showing 1-12 of 24

Last Updated: 09/26/2026